Medscape: How primary care doctors can contribute to epilepsy care
February 16, 2024
Medscape highlighted Project ECHO, a program piloted at the University of Cincinnati that trains primary care providers to manage epilepsy.
February 16, 2024
Medscape highlighted Project ECHO, a program piloted at the University of Cincinnati that trains primary care providers to manage epilepsy.
April 23, 2024
Local 12 spoke with patient Shane Shapiro and the University of Cincinnati's Laura Ngwenya about the importance of wearing a helmet following Shapiro's traumatic brain injury and recovery.
May 9, 2024
Memphis, Tennessee television station Action News 5 featured research from the University of Cincinnati's Laura Ngwenya and Jed Hartings that is testing the first treatments for spreading depolarizations, abnormal brain activity also called a "brain tsunami."
April 15, 2024
The University of Cincinnati's Carla Justiniano spoke with Healthline about colorectal cancer in an article about a woman diagnosed with cancer when she was seven months pregnant.
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.
April 11, 2024
The University of Cincinnati's Susan Pinney was featured in the New York Times and National Geographic in stories on the EPA's recent requirement that municipal water systems remove six synthetic chemicals linked to cancer and other health problems that are present in the tap water of hundreds of millions of Americans.
March 29, 2024
The University of Cincinnati's Amanda Jackson spoke with U.S. News & World Report about ovarian cancer risk factors and prevention.
April 19, 2024
The University of Cincinnati's Leeya Pinder was featured in an Alabama.com/Reckon article about how self-testing for HPV could make preventative care more accessible to those facing the most barriers.
March 19, 2024
MSN and Neurology Live covered the results of a phase 3 trial co-led by a University of Cincinnati researcher that found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.